ID

15593

Beschreibung

ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00046514

Link

https://clinicaltrials.gov/show/NCT00046514

Stichworte

  1. 04.06.16 04.06.16 -
Hochgeladen am

4. Juni 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Neoplasms NCT00046514

Eligibility Breast Neoplasms NCT00046514

Criteria
Beschreibung

Criteria

if female, non-pregnant and not lactating, with a negative serum pregnancy test, and either not of child-bearing potential or practicing an approved contraception method
Beschreibung

negative serum pregnancy test

Datentyp

boolean

Alias
UMLS CUI [1]
C0430061
eighteen years of age or older
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
karnofsky perfomance status of 70% or 0-2 swog performance status
Beschreibung

karnofsky perfomance status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
no other malignancy, except non-melanoma skin cancer, cin, or in-situ cervical cancer
Beschreibung

no other malignancy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205394
measurable disease
Beschreibung

measurable disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
suitable candidate for treatment with paclitaxel
Beschreibung

treatment with paclitaxel

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0144576
UMLS CUI [1,2]
C0332149
previously treated with taxol weekly or every three weeks, including adjuvant therapy, for metastatic breast cancer and relapsed within 12 months
Beschreibung

previously treated with taxol

Datentyp

boolean

Alias
UMLS CUI [1]
C0144576
if, at baseline, patient has absolute neutrophil count of at least 1500 cells/mm3, platelet count of at least 100,000 cells/mm3,and hemoglobin of at least 9 g/dl
Beschreibung

blood

Datentyp

boolean

Alias
UMLS CUI [1]
C0019046
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0005821
if, at baseline, patient has ast and alt of less than or equal to 2.5 x the upper limit of normal range; a total bilirubin less than or equal to 1.5 mg/dl; creatinine levels less than or equal to 2 mg/dl; and alkaline phosphatase levels less than or equal to 5 x the upper limit of normal range (unless there are bone but not liver metastases)
Beschreibung

blood measurements baseline

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201850
UMLS CUI [5]
C0201976
patient has an expected survival of at least 12 weeks
Beschreibung

expected survival

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
patient or his/her representative has signed an informed consent statement
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430

Ähnliche Modelle

Eligibility Breast Neoplasms NCT00046514

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
negative serum pregnancy test
Item
if female, non-pregnant and not lactating, with a negative serum pregnancy test, and either not of child-bearing potential or practicing an approved contraception method
boolean
C0430061 (UMLS CUI [1])
age
Item
eighteen years of age or older
boolean
C0001779 (UMLS CUI [1])
karnofsky perfomance status
Item
karnofsky perfomance status of 70% or 0-2 swog performance status
boolean
C0206065 (UMLS CUI [1])
no other malignancy
Item
no other malignancy, except non-melanoma skin cancer, cin, or in-situ cervical cancer
boolean
C0006826 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
measurable disease
Item
measurable disease
boolean
C1513041 (UMLS CUI [1])
treatment with paclitaxel
Item
suitable candidate for treatment with paclitaxel
boolean
C0144576 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
previously treated with taxol
Item
previously treated with taxol weekly or every three weeks, including adjuvant therapy, for metastatic breast cancer and relapsed within 12 months
boolean
C0144576 (UMLS CUI [1])
blood
Item
if, at baseline, patient has absolute neutrophil count of at least 1500 cells/mm3, platelet count of at least 100,000 cells/mm3,and hemoglobin of at least 9 g/dl
boolean
C0019046 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0005821 (UMLS CUI [3])
blood measurements baseline
Item
if, at baseline, patient has ast and alt of less than or equal to 2.5 x the upper limit of normal range; a total bilirubin less than or equal to 1.5 mg/dl; creatinine levels less than or equal to 2 mg/dl; and alkaline phosphatase levels less than or equal to 5 x the upper limit of normal range (unless there are bone but not liver metastases)
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
expected survival
Item
patient has an expected survival of at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
informed consent
Item
patient or his/her representative has signed an informed consent statement
boolean
C0021430 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video